Cancer

News on cancer research & diagnostics, liquid biopsy, and cancer risk testing.

The project aims to developa system to automate the coring of tumor samples based on identified targets for DNA and RNA extraction.

The Belgian company recently received €3.6 million to develop the signature into a clinical test within the next three years.

Investigators studied 442 patients with CUP and found mutations that could inform a specific treatment decision in more than half of them.

Investigators will use Biocept's liquid biopsy tests to detect ALK rearrangements both at baseline and to monitor treatment response and resistance mechanisms.

Using data from TCGA and the HPA, they looked at the prognostic role of each protein-coding gene in 7,932 tumor samples spanning 17 different tumor types.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sep
20
Sponsored by
Ion Torrent

This webinar will discuss how next-generation sequencing (NGS) can help clinical research labs and pathologists save time, money, and samples compared to single-analyte oncology research assays.

Sep
21
Sponsored by
Roche

This webinar will demonstrate a new approach that combines precise FFPE tumor isolation with extraction-free DNA/RNA library preparation to minimize material losses and reduce the amount of tissue input required for NGS analysis.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.